| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 138, 1335-1347, Copyright © 1991 by American Society for Investigative Pathology
REGULAR ARTICLES |
RO Schlingemann, FJ Rietveld, F Kwaspen, PC van de Kerkhof, RM de Waal and DJ Ruiter
Department of Pathology, Nijmegen University Cancer Center, The Netherlands.
The structure and function of the tumor microvasculature is of great interest for cancer biology, diagnosis, and therapy. The distribution of endothelial cells, pericytes, and basal lamina in tumors is not well documented. In this study, the authors investigated the distribution of markers for these different components in a series of malignant human tumors and in human granulation tissue, both situations with extensive angiogenesis. Their results show a striking heterogeneity in the expression of markers for pericytes and endothelial cells between different tumors, but also within a single tumor lesion. To be able to distinguish between these two adjacent cell types decisively, all marker studies were carried out both on the light and the electron microscopical level and compared with staining results in granulation tissue of cutaneous wounds in healthy volunteers and of decubitus lesions. In granulation tissue of decubitus lesions, well-defined zones with increasing levels of maturation can be delineated. It was found that antibodies recognizing von Willebrand factor often failed to stain the tumor capillaries. Of the pericyte markers, alpha-smooth muscle actin was only locally expressed by pericytes in the tumor vasculature, whereas the high-molecular-weight melanoma-associated antigen, a chondroitin sulfate proteoglycan, stained the microvasculature broadly. Staining of the basal lamina components collagen type IV and laminin was, within the tumor, not restricted to the microvasculature. From their findings the authors conclude that 1) for the visualization of the tumor vasculature, antibodies recognizing endothelial markers, especially monoclonal antibodies PAL-E and BMA 120, are preferable to those recognizing pericytes or basal lamina; 2) within the microvasculature of tumors and granulation tissue, a heterogeneity of expression of endothelial and pericyte markers is observed; 3) during the formation of granulation tissue, all three microvascular components can be demonstrated already in the histologically earliest stage, suggesting not only an involvement of endothelial cells but also of pericytes and basal lamina in the initial steps of angiogenesis in wound healing.
This article has been cited by other articles:
 |
|
 |
|
  J. Andrae, R. Gallini, and C. Betsholtz Role of platelet-derived growth factors in physiology and medicine Genes & Dev., May 15, 2008; 22(10): 1276 - 1312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. T. Dang, S. Y. Chun, K. Burkitt, M. Abe, S. Chen, P. Havre, N. J. Mabjeesh, E. I. Heath, N. J. Vogelzang, M. Cruz-Correa, et al. Hypoxia-Inducible Factor-1 Target Genes as Indicators of Tumor Vessel Response to Vascular Endothelial Growth Factor Inhibition Cancer Res., March 15, 2008; 68(6): 1872 - 1880. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. G. McDonald, K. Yang, H. R. Roberts, D. M. Monroe, and M. Hoffman Perivascular tissue factor is down-regulated following cutaneous wounding: implications for bleeding in hemophilia Blood, February 15, 2008; 111(4): 2046 - 2048. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Jaalouk, M. G. Ozawa, J. Sun, J. Lahdenranta, R. O. Schlingemann, R. Pasqualini, and W. Arap The Original Pathologische Anatomie Leiden-Endothelium Monoclonal Antibody Recognizes a Vascular Endothelial Growth Factor Binding Site within Neuropilin-1 Cancer Res., October 15, 2007; 67(20): 9623 - 9629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Bondjers, L. He, M. Takemoto, J. Norlin, N. Asker, M. Hellstrom, P. Lindahl, and C. Betsholtz Microarray analysis of blood microvessels from PDGF-B and PDGF-R{beta} mutant mice identifies novel markers for brain pericytes FASEB J, August 1, 2006; 20(10): 1703 - 1705. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. G. Bagley, W. Weber, C. Rouleau, and B. A. Teicher Pericytes and Endothelial Precursor Cells: Cellular Interactions and Contributions to Malignancy Cancer Res., November 1, 2005; 65(21): 9741 - 9750. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Berger, G. Bergers, B. Arnold, G. J. Hammerling, and R. Ganss Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization Blood, February 1, 2005; 105(3): 1094 - 1101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E J Kuiper, A N Witmer, I Klaassen, N Oliver, R Goldschmeding, and R O Schlingemann Differential expression of connective tissue growth factor in microglia and pericytes in the human diabetic retina Br. J. Ophthalmol., August 1, 2004; 88(8): 1082 - 1087. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. N. Witmer, B. C. van Blijswijk, C. J.F. van Noorden, G. F.J.M. Vrensen, and R. O. Schlingemann In Vivo Angiogenic Phenotype of Endothelial Cells and Pericytes Induced by Vascular Endothelial Growth Factor-A J. Histochem. Cytochem., January 1, 2004; 52(1): 39 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Anderson, A. M. Ponce, and R. J. Price Absence of OX-43 antigen expression in invasive capillary sprouts: identification of a capillary sprout-specific endothelial phenotype Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H346 - H353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y Li, M C Madigan, K Lai, R M Conway, F A Billson, R Crouch, and B J Allen Human uveal melanoma expresses NG2 immunoreactivity Br. J. Ophthalmol., May 1, 2003; 87(5): 629 - 632. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. C. Manegold, J. Hutter, S. A. Pahernik, K. Messmer, and M. Dellian Platelet-endothelial interaction in tumor angiogenesis and microcirculation Blood, March 1, 2003; 101(5): 1970 - 1976. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E S Bamberger and C W Perrett Angiogenesis in epithelian ovarian cancer Mol. Pathol., December 1, 2002; 55(6): 348 - 359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N. Witmer, J. Dai, H. A. Weich, G. F.J.M. Vrensen, and R. O. Schlingemann Expression of Vascular Endothelial Growth Factor Receptors 1, 2, and 3 in Quiescent Endothelia J. Histochem. Cytochem., June 1, 2002; 50(6): 767 - 778. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Sevigny, C. Sundberg, N. Braun, O. Guckelberger, E. Csizmadia, I. Qawi, M. Imai, H. Zimmermann, and S. C. Robson Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation Blood, April 15, 2002; 99(8): 2801 - 2809. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Morikawa, P. Baluk, T. Kaidoh, A. Haskell, R. K. Jain, and D. M. McDonald Abnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in Tumors Am. J. Pathol., March 1, 2002; 160(3): 985 - 1000. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Abramsson, O. Berlin, H. Papayan, D. Paulin, M. Shani, and C. Betsholtz Analysis of Mural Cell Recruitment to Tumor Vessels Circulation, January 1, 2002; 105(1): 112 - 117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Clarijs, L. Schalkwijk, D. J. Ruiter, and R. M. W. de Waal Lack of Lymphangiogenesis Despite Coexpression of VEGF-C and Its Receptor Flt-4 in Uveal Melanoma Invest. Ophthalmol. Vis. Sci., June 1, 2001; 42(7): 1422 - 1428. [Abstract] [Full Text]
|
|
|
|
|
|
L. Wyder, A. Vitaliti, H. Schneider, L. W. Hebbard, D. R. Moritz, M. Wittmer, M. Ajmo, and R. Klemenz Increased Expression of H/T-Cadherin in Tumor-penetrating Blood Vessels Cancer Res., September 1, 2000; 60(17): 4682 - 4688. [Abstract] [Full Text]
|
|
|
|
|
|
M. S. Seo, N. Okamoto, M. A. Vinores, S. A. Vinores, S. F. Hackett, H. Yamada, E. Yamada, N. L. Derevjanik, W. LaRochelle, D. J. Zack, et al. Photoreceptor-Specific Expression of Platelet-Derived Growth Factor-B Results in Traction Retinal Detachment Am. J. Pathol., September 1, 2000; 157(3): 995 - 1005. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Yao, S. E. Pike, J. Setsuda, J. Parekh, G. Gupta, M. Raffeld, E. S. Jaffe, and G. Tosato Effective targeting of tumor vasculature by the angiogenesis inhibitors vasostatin and interleukin-12 Blood, September 1, 2000; 96(5): 1900 - 1905. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Nathanson, R. J. Zarbo, D. L. Wachna, C. A. Spence, T. A. Andrzejewski, and J. Abrams Microvessels That Predict Axillary Lymph Node Metastases in Patients With Breast Cancer Arch Surg, May 1, 2000; 135(5): 586 - 594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Burg, R. Pasqualini, W. Arap, E. Ruoslahti, and W. B. Stallcup NG2 Proteoglycan-binding Peptides Target Tumor Neovasculature Cancer Res., June 1, 1999; 59(12): 2869 - 2874. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lauren, Y. Gunji, and K. Alitalo Is Angiopoietin-2 Necessary for the Initiation of Tumor Angiogenesis? Am. J. Pathol., November 1, 1998; 153(5): 1333 - 1339. [Full Text] [PDF]
|
|
|
|
|
|
B. Sauter, D. Foedinger, B. Sterniczky, K. Wolff, and K. Rappersberger Immunoelectron Microscopic Characterization of Human Dermal Lymphatic Microvascular Endothelial Cells: Differential Expression of CD31, CD34, and Type IV Collagen with Lymphatic Endothelial Cells vs Blood Capillary Endothelial Cells in Normal Human Skin, Lymphangioma, and Hemangioma In Situ J. Histochem. Cytochem., February 1, 1998; 46(2): 165 - 176. [Abstract] [Full Text]
|
|
|
|
|
|
A. W. Griffioen, M. J.H. Coenen, C. A. Damen, S. M.M. Hellwig, D. H.J. van Weering, W. Vooys, G. H. Blijham, and G. Groenewegen CD44 Is Involved in Tumor Angiogenesis; an Activation Antigen on Human Endothelial Cells Blood, August 1, 1997; 90(3): 1150 - 1159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Garlanda and E. Dejana Heterogeneity of Endothelial Cells : Specific Markers Arterioscler. Thromb. Vasc. Biol., July 1, 1997; 17(7): 1193 - 1202. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
